Home Articles

Articles

Welcome to the ARCHIVE of Pharma Marketing News articles. All articles are FREE! No subscription is required to download these articles from past issues. Articles become available to non-subscribers approximately two months after publication. To obtain articles as soon as they are published, you must subscribe to the email newsletter service. Subscription is free and supported by advertising.

Pharma C-Suite Social Media Dummies: Senior Execs Must Start ‘Carrying the [Digital] Bag’

Do pharma C-level executives really need to use social media directly or is it adequate that they see the value of social media within their organizations and ensure that others have the experience necessary to manage social media? This article attempts to answer that question with the help of Alexandra Fulford, an independent pharmaceutical industry strategy consultant who has worked with several pharmaceutical companies developing and running digital and social media training programs and workshops.

The Indian Pharmaceutical Market

The Indian pharmaceutical market is the world's fourth largest by volume (8% of global total) and thirteenth largest by value (less than 1% of global total).

PinUp: Big Pharma Racks Up Facebook Likes But Not So Much from Patients, Got...

Welcome to the March 24, 2017, issue of Pharma Industry News Update (aka PinUp). Let's contemplate how big drug companies can get hundreds of thousands of 'likes' on Facebook but score very low among patient groups worldwide. Only 25% of patients, for example, think pharma marketing is ethical. A case in point is Low-T direct-to-consumer advertising.

FDA Drops Social Media from Its Guidance Agenda: Focuses Instead on Responsding to “Unsolicited”...

FDA's revised draft guidance calendar for year 2011 is missing 'Promotion of Prescription Drug Products Using Social Media Tools,

PinUp: 2017: A Banner Year for Pharma Lobbying and TV Ads, Bumper Crop of...

Welcome to the December 19, 2017, issue of Pharma Industry News Update (aka PinUp). Now is when everyone looks back on the old year and begins thinking of the New Year. For pharma, 2017 saw a few highs in terms of money spent on lobbying - mostly to counteract calls for lower drug prices - and on TV advertising. Neither of which is surprising. But while the number of new drugs approved in 2017 eclipsed the 2016 number, profitability is not setting any new records, but may in fact be waning.

OpEd: Vioxx Withdrawal and the “Me-Too Drug Domino Effect”

Vioxx Withdrawal and the "Me-Too Drug Domino Effect" OpEd by John Mack Merck's "voluntary" withdrawal of Vioxx...

Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence

In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty.

eDetailing: Yesterday, Today and Tomorrow

eDetailing proponents, inside pharma companies and outside, use survey data to justify their arguments for greater spending on eDetails. In some cases, however, the numbers seem to show confusing trends and even may suggest that eDetailing may not be all that it's cracked up to be.

PinUp: FDA Lax on Medical Device Regulation, Caves In on Off-Label Promotion, & Passes...

Welcome to the January 16, 2018, issue of Pharma Industry News Update (aka PinUp). FDA is much in the news these days. The agency is lax in its regulation of medical devices and, depending on your point of view, it has either 'capitulated' to the drug industry and rolled back the regulation of off-label promotion or just decided to leave well enough alone.

Pharma Marketing News – eDetailing Special Supplement

This Special Supplement to Pharma Marketing News brings together in one convenient document several topics and case studies on eDetailing and ePromotion to physicians.

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -